Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention

Reperfusion After Fibrinolytic Therapy (RAFT): An open-label, multi-centre, randomised controlled trial of bivalirudin versus heparin in rescue percutaneous coronary intervention

Mostrar otras versiones (1)

<h4>Background</h4> The safety and efficacy profile of bivalirudin has not been examined in a randomised controlled trial of patients undergoing rescue PCI. <h4>Objectives</h4> We conducted an open-label, multi-centre, randomised controlled trial to compare bivalirudin with h...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Amir Faour, Nicholas Collins, Trent Williams, Arshad Khan, Craig P. Juergens, Sidney Lo, Darren L. Walters, Derek P. Chew, John K. French
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/f4856188c7e84802aac1111744cfcc9b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares